XENE
Xenon Pharmaceuticals Inc. · Healthcare
President and CEO Ian Mortimer sold $1.1M of Xenon Pharmaceuticals Inc.
Sold$1,142,513
$45.33Price
25,205Shares
−55%Stake
What XENE did after the filing
- The stock from Tue, Dec 9 close, $43.52
- −4.0%
- S&P 500, same days
- +1.7%
Measured over 30 trading days, to the Jan 23 close.
Traded Fri, Dec 5. Filed Tue, Dec 9, 2:40 PM ET, during the session. Returns use the Dec 9 close and the Jan 23 close. Not investment advice.